Rick Doblin, the founder of MAPS (the Multidisciplinary Association for Psychedelic Studies) explains why MDMA, psilocybin, LSD, and related drugs are finally ready for prime time.
Share this post
'Welcome to the psychedelic '20s!'
Share this post
Rick Doblin, the founder of MAPS (the Multidisciplinary Association for Psychedelic Studies) explains why MDMA, psilocybin, LSD, and related drugs are finally ready for prime time.